1. Home
  2. ICD-10-CM MS-DRG V42.0
  3. Diagnosis Codes in MS-DRG 740 - Uterine And Adnexa Procedures For Non-Ovarian And Non-Adnexal Malignancy With CC

Diagnosis Codes in MS-DRG 740 - Uterine And Adnexa Procedures For Non-Ovarian And Non-Adnexal Malignancy With CC

The Medicare Severity Diagnosis-Related Group (MS-DRG) is a patient classification system used to categorize hospital cases based on clinical similarity and expected resource use. MS-DRGs organize all possible principal diagnoses into mutually exclusive groups known as Major Diagnostic Categories (MDCs), which help determine reimbursement under the Medicare Inpatient Prospective Payment System.

This section lists the diagnosis codes included in MS-DRG V42.0: Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC from October 1, 2024, through September 30, 2025.

MS-DRG: 740

MS-DRG Title: Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC

MCD: 13

Relative Weight: 1.8182 Relative Weight
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Geometric LOS: 1.82 Geometric Length of Stay
The geometric mean length of stay (GMLOS) is used by Medicare to calculate the reimbursement for patients whose medical treatment takes a much longer or shorter time than average.

Arithmetic LOS: 2.70 Arithmetic Length of Stay
The average length of stay (ALOS) reflects the average number of days a patient spends in a hospital for each admission.

  • -

    • C52 - Malignant neoplasm of vagina

    • C55 - Malignant neoplasm of uterus, part unspecified

    • C58 - Malignant neoplasm of placenta

  • C51 - Malignant neoplasm of vulva

    • C51.0 - Malignant neoplasm of labium majus

    • C51.1 - Malignant neoplasm of labium minus

    • C51.2 - Malignant neoplasm of clitoris

    • C51.8 - Malignant neoplasm of overlapping sites of vulva

    • C51.9 - Malignant neoplasm of vulva, unspecified

  • C53 - Malignant neoplasm of cervix uteri

    • C53.0 - Malignant neoplasm of endocervix

    • C53.1 - Malignant neoplasm of exocervix

    • C53.8 - Malignant neoplasm of overlapping sites of cervix uteri

    • C53.9 - Malignant neoplasm of cervix uteri, unspecified

  • C54 - Malignant neoplasm of corpus uteri

    • C54.0 - Malignant neoplasm of isthmus uteri

    • C54.1 - Malignant neoplasm of endometrium

    • C54.2 - Malignant neoplasm of myometrium

    • C54.3 - Malignant neoplasm of fundus uteri

    • C54.8 - Malignant neoplasm of overlapping sites of corpus uteri

    • C54.9 - Malignant neoplasm of corpus uteri, unspecified

  • C56 - Malignant neoplasm of ovary

    • C56.1 - Malignant neoplasm of right ovary

    • C56.2 - Malignant neoplasm of left ovary

    • C56.3 - Malignant neoplasm of bilateral ovaries

    • C56.9 - Malignant neoplasm of unspecified ovary

  • C57 - Malignant neoplasm of other and unspecified female genital organs

    • C57.3 - Malignant neoplasm of parametrium

    • C57.4 - Malignant neoplasm of uterine adnexa, unspecified

    • C57.7 - Malignant neoplasm of other specified female genital organs

    • C57.8 - Malignant neoplasm of overlapping sites of female genital organs

    • C57.9 - Malignant neoplasm of female genital organ, unspecified

  • C57.0 - Malignant neoplasm of fallopian tube

    • C57.00 - Malignant neoplasm of unspecified fallopian tube

    • C57.01 - Malignant neoplasm of right fallopian tube

    • C57.02 - Malignant neoplasm of left fallopian tube

  • C57.1 - Malignant neoplasm of broad ligament

    • C57.10 - Malignant neoplasm of unspecified broad ligament

    • C57.11 - Malignant neoplasm of right broad ligament

    • C57.12 - Malignant neoplasm of left broad ligament

  • C57.2 - Malignant neoplasm of round ligament

    • C57.20 - Malignant neoplasm of unspecified round ligament

    • C57.21 - Malignant neoplasm of right round ligament

    • C57.22 - Malignant neoplasm of left round ligament

  • C76 - Malignant neoplasm of other and ill-defined sites

    • C76.3 - Malignant neoplasm of pelvis

  • C79.6 - Secondary malignant neoplasm of ovary

    • C79.60 - Secondary malignant neoplasm of unspecified ovary

    • C79.61 - Secondary malignant neoplasm of right ovary

    • C79.62 - Secondary malignant neoplasm of left ovary

    • C79.63 - Secondary malignant neoplasm of bilateral ovaries

  • C79.8 - Secondary malignant neoplasm of other specified sites

    • C79.82 - Secondary malignant neoplasm of genital organs

  • D06 - Carcinoma in situ of cervix uteri

    • D06.0 - Carcinoma in situ of endocervix

    • D06.1 - Carcinoma in situ of exocervix

    • D06.7 - Carcinoma in situ of other parts of cervix

    • D06.9 - Carcinoma in situ of cervix, unspecified

  • D07 - Carcinoma in situ of other and unspecified genital organs

    • D07.0 - Carcinoma in situ of endometrium

    • D07.1 - Carcinoma in situ of vulva

    • D07.2 - Carcinoma in situ of vagina

  • D07.3 - Carcinoma in situ of other and unspecified female genital organs

    • D07.30 - Carcinoma in situ of unspecified female genital organs

    • D07.39 - Carcinoma in situ of other female genital organs

  • D39 - Neoplasm of uncertain behavior of female genital organs

    • D39.0 - Neoplasm of uncertain behavior of uterus

    • D39.2 - Neoplasm of uncertain behavior of placenta

    • D39.8 - Neoplasm of uncertain behavior of other specified female genital organs

    • D39.9 - Neoplasm of uncertain behavior of female genital organ, unspecified

  • D39.1 - Neoplasm of uncertain behavior of ovary

    • D39.10 - Neoplasm of uncertain behavior of unspecified ovary

    • D39.11 - Neoplasm of uncertain behavior of right ovary

    • D39.12 - Neoplasm of uncertain behavior of left ovary